Cui Yanzhi, Wang Yanyan, Zhang Ningzhi, He Jun, Huang Hui, Liu Fengling, Wei Suju, Dong Qian, Wu Jing, Lin Keke, Chen Weixi, Xiang Jiale, Jin Hui, Peng Zhiyu, Zhao Qiang, Li Wei, Jiang Da, Banerjee Santasree
Department of Internal Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China.
BGI Genomics, BGI-Shenzhen, Shenzhen, Guangdong 518083, P.R. China.
Oncol Lett. 2019 Mar;17(3):3350-3354. doi: 10.3892/ol.2019.9950. Epub 2019 Jan 21.
Inherited loss-of-function mutations in the tumor suppressor gene are associated with a high risk of ovarian cancer in the Chinese population. The current case report discusses a novel heterozygous insertion in gene, c.3195_3196insA, in a 54-year-old Chinese female with hereditary ovarian cancer. This frameshift mutation generates a premature stop codon at amino acid 1,076, which leads to a truncated BRCA2 protein instead of a wild-type BRCA2 protein with 3,418 amino acids. According to the Breast Cancer Information Core database, this mutation has not been previously reported. However, germline mutations of are a more prevalent cause of ovarian cancer in Chinese females compared with females in Western populations. The present study expands the mutational spectra of that is associated with ovarian cancer.
肿瘤抑制基因的遗传性功能丧失突变与中国人群患卵巢癌的高风险相关。本病例报告讨论了一名54岁患有遗传性卵巢癌的中国女性中,基因发生的一种新型杂合插入,即c.3195_3196insA。这种移码突变在第1076位氨基酸处产生一个过早的终止密码子,导致产生截短的BRCA2蛋白,而非具有3418个氨基酸的野生型BRCA2蛋白。根据乳腺癌信息核心数据库,此突变此前未见报道。然而,与西方人群中的女性相比,该基因的种系突变在中国女性中是卵巢癌更普遍的病因。本研究扩展了与卵巢癌相关的该基因突变谱。